Divisas / EXAS
EXAS: Exact Sciences Corporation
46.80
USD
0.82
(1.72%)
El tipo de cambio de EXAS de hoy ha cambiado un -1.72%. En este caso, el precio mínimo en el mercado ha alcanzado 46.63, mientras que el máximo ha alcanzado 47.72.
Siga la dinámica de la pareja de divisas Exact Sciences Corporation. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
EXAS News
- Zacks Perrigo to Report Q2 Earnings: What's in Store for the Stock?
- Zacks Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Zacks Charles River Q2 Earnings Preview: What's in Store for the Stock?
- Zacks Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
- Zacks Tempus AI Taps Growing ICI Market With New xM Assay
- Zacks Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
- Zacks Henry Schein to Report Q2 Earnings: What's in Store for the Stock?
- Zacks KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
- Zacks CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?
- Zacks Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now?
- Seeking Alpha Baron Discovery Fund Q2 2025 Commentary (BDFIX)
- Zacks Amarin Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
- Zacks Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
- Zacks Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Seeking Alpha Baron Health Care Fund Q2 2025 Shareholder Letter
- Zacks Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
- Zacks How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Investing Canaccord Genuity reiterates Buy rating on Exact Sciences stock ahead of study
- Zacks Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
- Zacks Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet
- Zacks Tempus AI Raises 2025 Financial Outlook: What's Backing It?
- Investing Exact Sciences to release Q2 2025 results on August 6
Rango diario
46.63
47.72
Rango anual
39.97
72.83
- Cierres anteriores
- 47.54
- Open
- 47.62
- Bid
- 46.80
- Ask
- 47.10
- Low
- 46.63
- High
- 47.72
- Volumen
- 4.880 K
- Cambio diario
- -1.72%
- Cambio mensual
- -11.45%
- Cambio a 6 meses
- -14.14%
- Cambio anual
- -15.05%
31 julio, jueves
11:30
USD
- Act.
- Pronós.
- Prev.
- 47.999 K
11:30
USD
- Act.
- Pronós.
- -68.3%
- Prev.
- -1.6%
12:30
USD
- Act.
- Pronós.
- 0.4%
- Prev.
- 0.2%
12:30
USD
- Act.
- Pronós.
- 2.6%
- Prev.
- 2.7%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- 0.1%
12:30
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.3%
12:30
USD
- Act.
- Pronós.
- 0.2%
- Prev.
- -0.1%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- -0.4%
12:30
USD
- Act.
- Pronós.
- 0.0%
- Prev.
- -0.3%
12:30
USD
- Act.
- Pronós.
- 0.9%
- Prev.
- 0.9%
12:30
USD
- Act.
- Pronós.
- 1.0%
- Prev.
- 1.2%
12:30
USD
- Act.
- Pronós.
- 0.7%
- Prev.
- 0.8%
12:30
USD
- Act.
- Pronós.
- 224 K
- Prev.
- 217 K
12:30
USD
- Act.
- Pronós.
- 1.966 M
- Prev.
- 1.955 M
12:30
USD
- Act.
- Pronós.
- 222.299 K
- Prev.
- 224.500 K
13:45
USD
- Act.
- Pronós.
- 42.4
- Prev.
- 40.4
14:00
USD
- Act.
- Pronós.
- 2.3%
- Prev.
- 2.0%
14:30
USD
- Act.
- Pronós.
- 2 B
- Prev.
- 23 B
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.245%
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.265%